809 related articles for article (PubMed ID: 21561392)
1. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
Zaccara G; Almas M; Pitman V; Knapp L; Posner H
Epilepsia; 2014 Jul; 55(7):1048-57. PubMed ID: 24902473
[TBL] [Abstract][Full Text] [Related]
4. The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: a post hoc analysis of combined clinical trials.
Tomson T; Almas M; Giordano S; Cabrera J
Epilepsy Res; 2011 Sep; 96(1-2):64-73. PubMed ID: 21624821
[TBL] [Abstract][Full Text] [Related]
5. Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials.
Uthman BM; Bazil CW; Beydoun A; Schulze-Bonhage A; Benabou R; Whalen E; Emir B; Griesing T; Leon T
Epilepsia; 2010 Jun; 51(6):968-78. PubMed ID: 20345940
[TBL] [Abstract][Full Text] [Related]
6. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin as adjunctive therapy for partial seizures.
Brodie MJ
Epilepsia; 2004; 45 Suppl 6():19-27. PubMed ID: 15315512
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
12. Reduction of secondarily generalized tonic-clonic (SGTC) seizures with pregabalin.
Briggs DE; Lee CM; Spiegel K; French JA
Epilepsy Res; 2008 Nov; 82(1):86-92. PubMed ID: 18752932
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of levetiracetam: a review of three pivotal clinical trials.
Privitera M
Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
15. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
16. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
Gidal BE; Ferry J; Majid O; Hussein Z
Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
[TBL] [Abstract][Full Text] [Related]
17. Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures.
Ramsay RE; Perucca E; Robbins J; Barrett JA; Spiegel K
Epilepsia; 2009 Aug; 50(8):1891-8. PubMed ID: 19490035
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
19. A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico).
Rivera-Castaño L; Leal-Cantu R; Abreu P; Guerrero M; Davila G
Epilepsy Res; 2012 Jun; 100(1-2):74-9. PubMed ID: 22304935
[TBL] [Abstract][Full Text] [Related]
20. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.
Baulac M; Leon T; O'Brien TJ; Whalen E; Barrett J
Epilepsy Res; 2010 Sep; 91(1):10-9. PubMed ID: 20696552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
